SRZN Competitors & Alternatives
Compare Surrozen Inc with similar stocks in the same industry
Biotechnology
SRZN
Main Stock$24.75
Tradestie Score
54
Market Cap
$117.07M
Revenue Growth
4.1%
Analyst Upside
+71.7%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.27
|
$304.12M | - | 60 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$21.90
|
$297.23M | - | 52 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$30.72
|
$293.03M | - | 58 | Compare |
|
OMER
Omeros Corporation
|
$10.58
|
$281.75M | 9.1 | 56 | Compare |
|
DBVT
DBV Technologies S.A.
|
$15.60
|
$275.54M | - | 55 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.05
|
$275.13M | - | 58 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$14.48
|
$269.08M | - | 56 | Compare |
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$8.62
|
$258.18M | - | 54 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$30.07
|
$256.54M | - | 61 | Compare |
More SRZN Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry